Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cronin

Showing results (381-390 of 554) with videos related to

Pageof 56
Sort By:
Health Services Research|July 26, 2018
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at DiagnosisDebra P Ritzwoller, Paul A Fishman, Matthew P Banegas, et al.
Blood Advances|November 9, 2022
Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapyRobert M Cronin, Kristin Wuichet, Djamila L Ghafuri, et al.
Hematology (Amsterdam, Netherlands)|March 30, 2018
Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell diseaseRobert M Cronin, Jane S Hankins, Jeannie Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomyMatthew Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Journal of Community Genetics|November 20, 2017
A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settingsHuma Q Rana, Sarah R Cochrane, Elaine Hiller, et al.
Mbio|March 6, 2024
The antagonistic transcription factors, EspM and EspN, regulate the ESX-1 secretion system in <i>M. marinum</i>Kathleen R Nicholson, Rachel M Cronin, Rebecca J Prest, et al.
JCO Precision Oncology|June 27, 2019
Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumorsJonathan M Marron, Angel M Cronin, Steven G DuBois, et al.
Cancer|October 21, 2010
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50Hans Lilja, Angel M Cronin, Anders Dahlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
The Bering Strait was flooded 10,000 years before the Last Glacial MaximumJesse R Farmer, Tamara Pico, Ona M Underwood, et al.
Medical Care|December 11, 2012
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohortsMichael J Hassett, Debra P Ritzwoller, Nathan Taback, et al.
Pageof 56

Showing results (381-390 of 554) with videos related to

Sort By:
Pageof 56
Health Services Research|July 26, 2018
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at DiagnosisDebra P Ritzwoller, Paul A Fishman, Matthew P Banegas, et al.
Blood Advances|November 9, 2022
Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapyRobert M Cronin, Kristin Wuichet, Djamila L Ghafuri, et al.
Hematology (Amsterdam, Netherlands)|March 30, 2018
Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell diseaseRobert M Cronin, Jane S Hankins, Jeannie Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomyMatthew Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Journal of Community Genetics|November 20, 2017
A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settingsHuma Q Rana, Sarah R Cochrane, Elaine Hiller, et al.
Mbio|March 6, 2024
The antagonistic transcription factors, EspM and EspN, regulate the ESX-1 secretion system in <i>M. marinum</i>Kathleen R Nicholson, Rachel M Cronin, Rebecca J Prest, et al.
JCO Precision Oncology|June 27, 2019
Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumorsJonathan M Marron, Angel M Cronin, Steven G DuBois, et al.
Cancer|October 21, 2010
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50Hans Lilja, Angel M Cronin, Anders Dahlin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
The Bering Strait was flooded 10,000 years before the Last Glacial MaximumJesse R Farmer, Tamara Pico, Ona M Underwood, et al.
Medical Care|December 11, 2012
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohortsMichael J Hassett, Debra P Ritzwoller, Nathan Taback, et al.
Pageof 56